NOW Aktie
WKN DE: A113R6 / ISIN: US67011P1003
|
15.11.2025 15:35:00
|
2 Beaten-Down Stocks to Avoid Right Now
The biotech industry is notoriously volatile. Drugmakers often face significant challenges that send their stocks plummeting. Sometimes that creates an attractive entry point, provided we can reasonably expect the company in question to bounce back. But at other times it's not worth investing in a biotech stock that has lost significant market value, as the risks are still too high.That's the case with Intellia Therapeutics (NASDAQ: NTLA) and Sarepta Therapeutics (NASDAQ: SRPT). These two biotechs have faced headwinds this year that have sent their share prices sinking, but investors should think twice before buying the dip.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NOW Inc When Issued
|
06.05.26 |
Ausblick: NOW mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
|
08.03.26 |
Latin America’s lithium triangle is now in the hands of the right (Financial Times) | |
|
07.03.26 |
Price is now the main ingredient in the office-lunch slop bowl (Financial Times) | |
|
07.03.26 |
Britain is now the home of the Middle Man (Financial Times) | |
|
05.03.26 |
Mildly dovish February ECB minutes are now stale (Financial Times) | |
|
05.03.26 |
Plunge in South Korean stocks saps an astounding market ride for now (Financial Times) | |
|
19.02.26 |
Ausblick: NOW gewährt Anlegern Blick in die Bücher (finanzen.net) | |
|
13.02.26 |
Politics is now driving the dollar (Financial Times) |
Analysen zu NOW Inc When Issued
Aktien in diesem Artikel
| NOW Inc When Issued | 12,10 | 0,00% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.